U098 Navigating Unchartered Waters: The Management of Autoimmune & Inflammatory Skin Disorders in Pregnant and Breastfeeding Patients
DESCRIPTION
Immunosuppressive, immunomodulatory, and biologic agents increasingly represent the mainstays of treatment for many autoimmune and inflammatory skin diseases including atopic dermatitis, alopecia areata, cutaneous lupus, psoriasis, vasculitis, and sclerosing disorders, among others. Many patients of reproductive potential are currently eligible to receive these medications, inevitably prompting questions regarding the risks borne by a developing fetus and whether these medications can be continued during conception, pregnancy, and/or breastfeeding. In a highly relevant, case-based format, this session will highlight available safety data for novel systemic agents in pregnancy and offer practical guidance from experts in high-risk maternal fetal medicine and rheumatologic-dermatology on the management of inflammatory/autoimmune skin diseases in this special population.
LEARNING OBJECTIVES
Review available safety data for commonly used biologics and immunosuppressive/immunomodulatory agents in pregnant and breastfeeding patients.
Select management options for patients with autoimmune and inflammatory disorders of the skin who are pregnant, breastfeeding, or trying to conceive.
SCHEDULE
4:30 PM
Management of Autoimmune & Inflammatory Skin Disorders in Pregnant and Breastfeeding Patients
DIRECTOR
Katharina Stephanie Shaw, MD, FAAD
SPEAKERS
Kathryn Rentfro, MD
Nicole Smith, MD, MPH
Harvard Medical School/Mass General Brigham Hospitals
DISCLOSURES
Kathryn Rentfro, MD
No financial relationships exist with ineligible companies.
Katharina Stephanie Shaw, MD, FAAD
Priovant – Employee (w-2 relationship)(Salary);
Nicole Smith, MD, MPH
No financial relationships exist with ineligible companies.